Test Price
2,800 AED✅ Home Collection Available
SEPT9 Gene Hereditary Neuralgic Amyotrophy (HNA) Genetic Test in UAE | AED 2,800
Executive Summary & Core Metrics
Accuracy Guarantee
99.9% Diagnostic Sensitivity via ISO 9001:2015 Certified Processing. NGS technology with full SEPT9 gene coverage.
Premium Logistics
VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection – Available daily from 8 AM to 11 PM across all Emirates.
Clinical Guidance
Telephonic Post-Test Clinical Interpretation Support from our Genetic Counsellor and Consultant Medical Geneticist.
Insurance & Billing
Direct Billing Verification via WhatsApp: +971 54 548 8731. All major UAE insurers accepted.
Test Overview & Methodology
Hereditary Neuralgic Amyotrophy (HNA) is an autosomal dominant disorder characterised by recurrent episodes of intense shoulder pain followed by muscle weakness and atrophy. Mutations in the SEPT9 gene are the most common cause; this NGS panel fully sequences all coding exons and exon‑intron boundaries to detect pathogenic, likely pathogenic, and variants of uncertain significance.
| Parameter | Our Test (NGS) | Closest Alternative (Sanger Sequencing) |
|---|---|---|
| Precision / Coverage | Full gene coding region ± 20 bp splice sites; detection of SNVs, indels, CNVs | Single‑exon, most common variants only |
| Method | Next‑Generation Sequencing (Illumina NovaSeq) with bioinformatic validation | Sanger dideoxy sequencing |
| Turnaround Time | 3–4 weeks | 4–6 weeks |
| Variant Interpretation | ClinVar, ACMG 2026 guidelines | Limited to literature |
Physician Insight & Safety Protocols
"As a Consultant Medical Genetics, I understand the emotional burden of recurrent brachial plexus attacks. This test provides molecular confirmation and enables early, personalised preventive measures. Please remember that a negative result does not exclude the diagnosis—clinical correlation remains paramount."
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Advisory – Important Safety Notice
⚠️ Medication Warning: Do not discontinue prescribed medication without consulting your doctor.
Exclusion Criteria & Emergency Red Flags
- Exclusion: This test is not indicated for acute diagnostic crisis; patients with active, rapidly progressive paralysis should first undergo neurological emergency assessment.
- Exclusion: Samples cannot be collected if the patient is under 18 years without legal guardian consent as per Federal Decree-Law No. 4 of 2016 on Medical Liability.
- ER Red Flag: Sudden onset of bilateral brachial weakness with respiratory distress – seek immediate medical attention.
- ER Red Flag: High fever ( > 38.5°C) with meningeal signs and concurrent arm pain – dial 998.
Patient FAQ & Clinical Guidance
1. What is the SEPT9 gene test for hereditary neuralgic amyotrophy?
This genetic test screens the entire SEPT9 coding sequence to identify pathogenic variants causing recurrent brachial plexus neuropathy, enabling early diagnosis and family risk counselling.
2. How is the sample collected and what preparation is required?
A painless blood draw is performed at your home by our licensed phlebotomist; you only need to complete a pre-genetic counselling session and provide a three-generation family pedigree.
3. How long do results take and who interprets them?
Results are delivered within 3 to 4 weeks; a board-certified clinical geneticist and neurologist jointly review the variant and provide a clinically actionable report.
UAE Regulatory & Data Privacy Adherence
DNA Labs UAE adheres to the highest data protection standards as mandated by Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All patient information is encrypted, securely stored, and never disclosed without prior written consent.
Clinical & Logistical Metadata
| Test Name | SEPT9 Gene Hereditary Neuralgic Amyotrophy (HNA) Genetic Test (Next-Generation Sequencing) |
| Price (AED) | 2,800 |
| Turnaround Time | 3–4 weeks |
| Sample Type / Matrix | Peripheral whole blood collected in EDTA tube (VIP Mobile Phlebotomy available daily from 8 AM to 11 PM) |
| Methodology Used | Next-Generation Sequencing (NGS) – Illumina NovaSeq; full gene coding region ± 20 bp splice sites; detection of SNVs, indels, CNVs |
| ICD-10-CM Code | G54.9 |
| LOINC Code | 77418-8 |
| DHA Facility License & Laboratory Address | DHA Facility License Number: 1143 Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE Corporate Lab: DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians